Shen Gang, Male, Medical Doctor, Post-doctoral Fellow, Chief Physician, Master's Supervisor. Director of the Interventional Vascular Anomalies Department at Beijing JingDu Children's Hospital, and Founder of the First Vascular Anomalies and Interventional Vascular Center in China. With nearly 30 years of experience in interventional treatment of pediatric vascular diseases, he has personally performed or participated in over 50,000 interventional surgeries, with an annual outpatient volume exceeding 6,000 visits. As a pioneer in the field of pediatric interventional treatment in China, he has deeply participated in the establishment of the first national pediatric interventional treatment base and training system, and leads the annual "China Pediatric Interventional Summit Forum".
Core Areas: Minimally invasive interventional treatment of pediatric hemangiomas, vascular malformations, and lymphatic diseases.
Subspecialties:
1.Vascular Diseases: Hemangioma, Klippel-Trenaunay Syndrome (KT Syndrome), Parkes-Weber Syndrome (PW Syndrome), renal artery stenosis
2.Lymphatic Diseases: Sclerotherapy for lymphangioma and lymphatic malformations
3.Pediatric Tumors: Interventional embolization for retinoblastoma and hepatoblastoma
4.Cerebrovascular Diseases: Cerebral angiography in infants and young children, interventional treatment of spinal vascular malformations
Member of the Society for Pediatric Interventional Radiology (SPIR)
Committee Member of the Vascular Malformation Professional Committee of the Chinese Chapter of the International Union of Vascular Societies (IUVs)
Executive Committee Member of the Pediatric Oncology Expert Committee of the Interventional Oncology Branch of the Chinese Anti-Cancer Association
Professional Title Certification: Chief Physician (Certified by the National Health Commission of China)
7-time "Annual Good Doctor"
"Strongest Young and Middle-aged Doctor in Guangdong Hospitals"
Doctor of Interventional Therapy;
Post-doctoral Fellow in Interventional Medicine at the University of Western Ontario, Canada.
Research Projects:
Leading a project funded by the Wu Jieping Medical Foundation: Clinical research on genetic diagnosis and targeted therapy for lymphatic malformations
Leading a Guangdong Provincial Science and Technology Plan Project: Mechanism research on miR-26b interventional targeted therapy for liver cancer
Academic Breakthroughs:
Published multiple research papers on interventional radiology, including 6 SCI-indexed papers with a total impact factor of 20.936, including 3 as the first author and 1 as the corresponding author (highest single impact factor: 5.266). Served as associate editor for Illustrated Atlas of Practical Clinical Interventional Diagnosis and Treatment (3rd Edition) and Pediatric Interventional Therapy, and contributed to CT and MRI Interventional Radiology and Practical Clinical Imaging Anatomy and Diagnosis.
Discovery of diagnostic biomarkers for infantile hemangioma (2022)
Proposal of a misdiagnosis correction protocol for pediatric lymphatic malformations complicated with venous malformations (2024)
Chinese (Mandarin) and Proficient in medical English
Books:
Associate Editor: Illustrated Atlas of Practical Clinical Interventional Diagnosis and Treatment (3rd Edition), Pediatric Interventional Radiology
Contributing Author: Chinese Medical Association Guidelines for the Diagnosis and Treatment of Hemangiomas and Vascular Malformations (2024), CT/MRI Interventional Radiology
Representative Papers:
1. Shen G, et al. Mechanism of miR-106b in regulating hepatocellular carcinoma cell proliferation (Carcinogenesis, IF=5.702)
2. Identification of diagnostic biomarkers for infantile hemangioma (Journal of Oncology, 2022)
3. Pingyangmycin sclerotherapy combined with catheter drainage for the treatment of giant lymphatic malformations in children (Chinese Journal of Medicine, 2024)
(Total of 6 SCI papers published, with a cumulative impact factor of 20.936)
Recommendation Rating: 5.0/5.0 (comprehensive score from patients)
Service Volume: Served 24,559 patients in total; published 17 warm-hearted records (liked 307 times)
Recent Reviews (2025):
"Clear explanations and kind attitude! Dr. LI hua carefully analyzed the hemangioma treatment plan, alleviating the whole family's worries." ——Patient Xiao***
"Highly experienced, extremely patient with young patients, and remarkable results from minimally invasive surgery." ——Anonymous Patient
Dr. Shen Gang is a leading figure in the field of pediatric interventional vascular diseases in China, combining clinical innovation (such as the first targeted therapy for lymphatic malformations), academic standardization (participation in national guideline formulation), and patient care (7-time "Good Doctor" certification). His team focuses on minimally invasive techniques to reduce treatment trauma in children, with research achievements directly driving innovations in clinical practice.
Note: Original sources and professional terminology have been calibrated using standardized medical terms (e.g., "hemangioma" instead of "vascular tumor"; "intervention" used as a cross-strait common term) to ensure consistency in professional expression.
EN
CN
